Help us understand the brain and make a world of difference to people facing devastating brain disorders, which account for over 20 per cent of the disease burden in Australia.
Together we can understand more about the brain, improve treatments and, importantly, develop preventative tools as well as long-term treatments for brain and mental health disorders such as dementia, schizophrenia, motor neurone disease, and anxiety and depression.
Philanthropy at QBI has helped us take our research to clinical trials and spend time following blue sky neuroscience to find answers to complex health challenges.
Why become a QBI philanthropic partner?
Thanks to the generosity of philanthropy, we've achieved major breakthroughs including:
A non-invasive ultrasound treatent for Alzheimer's disease
Professor Jürgen Götz, Director, Clem Jones Centre for Ageing Dementia Research (CJCADR) and his team are developing a ground-breaking therapeutic ultrasound approach to target dementia in their Scanning Ultrasound Research Program.
A potential treatment for motor neuron disease
Emeritus Professor Perry Bartlett, the inaugural QBI Director, and his colleagues Emeritus Professor Andrew Boyd and Dr Jing Zhao are now translating their research discoveries in motor neurone disease (MND) to human clinical trials. They are using a novel EpHA4 blocker to prevent the progression of MND.
Deep Brain Stimulation as an effective treatment for Parkinson's and OCD
Queensland Brain Institute (QBI) Director, Professor Pankaj Sah, Professor Peter Silburn, Dr Philip Mosley and Associate Professor Terry Coyne are using deep brain stimulation (DBS) technology to treat a range of neurological disorders such as Parkinson's and obsessive compulsive disorder (OCD).
The Brazil Family Foundation has had a major impact on our research
Lyn and Bobbie Brazil established the Brazil Family Program for Neurology in 2017, enabling us to support four laboratories.
Giving back: The McCusker Charitable Foundation
In April 2023, the McCusker Charitable Foundation made a generous philanthropic gift of $1 million to the Queensland Brain Institute (QBI) to fast-track research to develop its world-leading therapeutic ultrasound approach as a treatment for dementia and potential RNA therapies.